SCHEMBL1289840

SCHEMBL1289840

CC(C)(C)OC(=O)NCC(=O)NCC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
APLNR P35414 1/20 0.39
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.37
NPFFR1 Q9GZQ6 1/20 0.37
NPFFR2 Q9Y5X5 1/20 0.37
CA12 O43570 3/20 0.36
CA2 P00918 3/20 0.36
CA14 Q9ULX7 1/20 0.36
CA1 P00915 2/20 0.36
CA9 Q16790 2/20 0.36
EPHX1 P07099 1/20 0.36
SIGMAR1 Q99720 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23465643 0.89 TDP1 (0.42) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL4202727 0.87 TDP1 (0.48) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL7554680 0.85 TDP1 (0.44) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL13678549 0.85 TDP1 (0.44) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL19178271 0.85 TDP1 (0.44) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL24503827 0.84 TDP1 (0.47) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL23350894 0.84 TDP1 (0.43) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL20050532 0.83 TDP1 (0.44) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL15805765 0.83 TDP1 (0.47) TDP1MAOAMAOBMEN1KMT2A
SCHEMBL18843239 0.81 MEN1 (0.42) TDP1MAOAMAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250228239-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-07-17 US disclosed
US-11944099-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto CORTEVA AGRISCIENCE LLC (US) 2024-04-02 US disclosed
US-20230303482-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY 2023-09-28 US disclosed
US-20230303482-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY 2023-09-28 US disclosed
EP-3150575-B1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE DU PONT (US) 2023-08-09 EP disclosed
EP-3150575-B1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE DU PONT (US) 2023-08-09 EP disclosed
US-11613516-B2 Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide E. I. DU PONT DE NEMOURS AND COMPANY (US) 2023-03-28 US disclosed
CN-115536541-A Synthesis method of common intermediate of flurradine and afurane 湖北美天生物科技股份有限公司 2022-12-30 CN disclosed
EP-3971166-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETO Corteva Agriscience LLC (US) 2022-03-23 EP disclosed
EP-3971166-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETO Corteva Agriscience LLC (US) 2022-03-23 EP disclosed
US-20130267729-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2013-10-10 US disclosed
US-20130267729-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2013-10-10 US disclosed
EP-2621894-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. Du Pont De Nemours And Company (US) 2013-08-07 EP disclosed
US-20130131053-A1 ISOXAZOLINE DERIVATIVES AS PESTICIDES NOVARTIS TIERGESUNDHEIT AG (CH) 2013-05-23 US disclosed
US-8383659-B2 Isoxazoline derivatives as pesticides NOVARTIS AG (CH) 2013-02-26 US disclosed
EP-2379537-B1 Isoxazoline derivatives and their use as pesticide NOVARTIS AG (CH) 2012-10-31 EP disclosed
WO-2012107533-A1 ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS NOVARTIS AG (CH) 2012-08-16 WO disclosed
WO-2012047543-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-12 WO disclosed
WO-2012047543-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-04-12 WO disclosed
US-20110245239-A1 ORGANIC COMPOUNDS ELANCO TIERGESUNDHEIT AG (CH) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303482-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE NAAA, SAT1, NAA15 TDP1 1121/4885MAOA 197/4885MAOB 399/4885
US-11944099-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto ACHE, DDT, MLYCD TDP1 683/4885MAOA 539/4885MAOB 998/4885
US-20130131053-A1 ISOXAZOLINE DERIVATIVES AS PESTICIDES CYP3A7, ACHE, CYP4X1 TDP1 2683/4885MAOA 1426/4885MAOB 1784/4885
US-11613516-B2 Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide NAAA, SAT1, NAA15 TDP1 1013/4885MAOA 174/4885MAOB 371/4885
US-20250228239-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO ACHE, DDT, MLYCD TDP1 683/4885MAOA 539/4885MAOB 998/4885
US-20110245239-A1 ORGANIC COMPOUNDS ACHE, VDAC1, VDAC2 TDP1 1361/4885MAOA 282/4885MAOB 396/4885
US-20130267729-A1 METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE NAAA, SAT1, NAA15 TDP1 1013/4885MAOA 174/4885MAOB 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.